Record

Ref NoRCP/COL/9/874
TitleConsultation response to the National Institute for Health and Clinical Excellence on 'Proposed Remit for Single Technology Appraisal: Natalizumab for the treatment of moderate to severe Crohn's disease'
Date2006
Extent1 file
Add to My Items